Source: Drug Delivery Business

Flowonix: FDA approves Flowonix's Prometra II programmable pump

Flowonix Medical has won FDA approval for its Prometra II 40 ml programmable pump and its associated software for intrathecal infusion. The pump has expanded reservoir size options that include 20 ml and 40ml pumps, along with the claim of 10-year battery life at average flow rates. Flowonix said in a news release yesterday that [...]The post FDA approves Flowonix's Prometra II programmable pump appeared first on Drug Delivery Business.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Steve Adler's photo - CEO of Flowonix

CEO

Steve Adler

CEO Approval Rating

69/100

Read more